CD8A and neoplasm: (A) Absolute number and (B) Fold change in number of circulating lung CD4 and CD8 T cells of tumor bearing CCSP-rtTA; TetO-EGFRL858R mice in the absence (−) and presence (+) of erlotinib for 2 weeks.